First-episode psychosis revealing a low-grade astrocytoma in an adolescent with refractory focal epilepsy: A case report
Keywords:
first-episode psychosis, low-grade astrocytoma, refractory focal epilepsyAbstract
Background: Brain tumours may present first with psychiatric symptoms; in a review of 165 published cases, 10.3% had psychiatric symptoms alone. Recognition is harder in adolescents, in whom first-episode psychosis is usually attributed to primary psychiatric illness. Neuroimaging is recommended when red flags such as seizures or functional decline are present.
Case description and management: A 17-year-old girl presented with six days of persecutory delusions, disorganised speech and insomnia, preceded by two to three months of irritability, fatigue and academic decline. She had focal epilepsy since the age of 10, with two to three brief seizures monthly in the preceding year despite good adherence; the last was four days before psychosis onset. No neuroimaging had ever been performed, reflecting limited access in peripheral settings. Examination, blood tests, electrocardiogram and cerebrospinal fluid parameters, including an autoimmune encephalitis panel, were normal. Contrast magnetic resonance imaging showed a 5.0 x 3.7 x 3.5 cm left temporo-parietal and capsuloganglionic lesion. Risperidone 2 mg/day, increased to 4 mg/day, was given with sodium valproate 1000 mg/day and clobazam 10 mg/day. Maximal safe resection with intraoperative language mapping followed two weeks later; integrated histopathological and molecular assessment confirmed isocitrate dehydrogenase mutant astrocytoma, WHO Classification of CNS Tumours, 5th edition grade 2, Ki-67 approximately 2%. Seizures ceased immediately after surgery and psychosis remitted gradually; she remained well at two months.
Conclusion: Adolescent first-episode psychosis with refractory epilepsy and functional decline warrants urgent neuroimaging, as it may reveal an occult astrocytoma. Recovery followed the combination of resection, antiseizure optimisation and antipsychotic treatment.
8
14 PDF
5 Review report
2
References
Madhusoodanan S, Ting MB, Farah T, Ugur U. Psychiatric aspects of brain tumors: a review. World J Psychiatry. 2015;5(3):273-285. doi: https://doi.org/10.5498/wjp.v5.i3.273
Ghandour F, Squassina A, Karaky R, Diab-Assaf M, Fadda P, Pisanu C. Presenting psychiatric and neurological symptoms and signs of brain tumors before diagnosis: a systematic review. Brain Sci. 2021;11(3):301. doi: https://doi.org/10.3390/brainsci11030301
Sherman SJ, Tanaka R, Qaddoumi I. Psychiatric symptoms in children with low-grade glioma and craniopharyngioma: a systematic review. J Psychiatr Res. 2022;148:240-249. doi: https://doi.org/10.1016/j.jpsychires.2022.01.056
Chen X, Yang JZ, Kong LY, Li ZY, Tang F, Li ZQ. Research progress in glioma-related epilepsy (Review). Biomed Rep. 2025;23(4):167. doi: https://doi.org/10.3892/br.2025.2045
Expert Panel on Neurological Imaging; Soares BP, Shih RY, Utukuri PS, Adamson M, Austin MJ, Brown RKJ, Burns J, Cacic K, Chu S, Crone C, Ivanidze J, Jackson CD, Kalnins A, Potter CA, Rosen S, Soderlund KA, Thaker AA, Wang LL, Policeni B. ACR Appropriateness Criteria® Altered Mental Status, Coma, Delirium, and Psychosis: 2024 Update. J Am Coll Radiol. 2024 Nov;21(11S):S372-S383. doi: https://doi.org/10.1016/j.jacr.2024.08.018
Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016 Apr;15(4):391-404. doi: https://doi.org/10.1016/S1474-4422(15)00401-9
Arora A, Prakash P, Rizzo L, Blackman G, David AS, Rogers JP. Effectiveness of antipsychotic drug therapy for treating psychosis in people with epilepsy: a systematic review. Epilepsia. 2024;65(12):3425-3440. doi: https://doi.org/10.1111/epi.18123
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: https://doi.org/10.1093/neuonc/noab106
Sun S, Malicki D, Levy M, Crawford JR. Psychiatric presentation of a secondary high-grade glioma in a teenager with high-risk pre-B-cell acute lymphoid leukaemia in remission. BMJ Case Rep. 2021 Sep 3;14(9):e246249. doi: https://doi.org/10.1136/bcr-2021-246249
Jules-Dole N, Uribe-Cardenas R, McReynolds LJ, Borden L, Chambers S, Bell WR, Ahn ES, Raabe E, Salpekar JA. Psychosis Remitted After Ependymoma Resection in a School-Aged Child. J Neuropsychiatry Clin Neurosci. 2020 Summer;32(3):305-308. doi: https://doi.org/10.1176/appi.neuropsych.19070147
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Shams Ibne Karim, Prajna Pranamita Das Gupta, Farzana Yeasmin, Nahid Mahjabin Morshed, Sifat E Syed

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.